Serum cardiac troponin I concentrations decrease following treatment of primary immune-mediated haemolytic anaemia

J Small Anim Pract. 2015 Aug;56(8):516-20. doi: 10.1111/jsap.12379. Epub 2015 Jul 2.

Abstract

Objectives: The measurement of serum cardiac troponin I concentrations in dogs with a range of non-primary cardiac illnesses suggests that cardiac myocyte damage is commonplace. Dogs with primary immune-mediated haemolytic anaemia have increased serum cardiac troponin I concentrations at the time of diagnosis. However, it is unclear whether biochemical evidence of cardiac myocyte damage improves following successful treatment of anaemia.

Methods: A haematology profile was performed and serum cardiac troponin I concentrations were measured in 19 dogs with primary immune-mediated haemolytic anaemia before and after treatment.

Results: The haematocrit increased significantly (P = 0 · 0001) following treatment of primary IMHA (median pre: 0 · 13 L/L, median post: 0 · 33 L/L). The serum cardiac troponin I concentrations decreased significantly (P < 0 · 05) after treatment (median pre: 0 · 26 ng/mL, median post: 0 · 16 ng/mL).

Clinical significance: Serum cardiac troponin I concentration decreases following successful treatment of primary immune-mediated haemolytic anaemia. The clinical and prognostic significance of serum cardiac troponin I concentrations before and after treatment in dogs with primary immune-mediated haemolytic anaemia merits further investigation.

Publication types

  • Comparative Study

MeSH terms

  • Anemia, Hemolytic / blood
  • Anemia, Hemolytic / veterinary*
  • Animals
  • Biomarkers / blood*
  • Dog Diseases / blood*
  • Dogs
  • Female
  • Hematocrit / veterinary
  • Male
  • Troponin I / blood*

Substances

  • Biomarkers
  • Troponin I